Literature DB >> 27158897

Prevalence and Predictors of Generic Drug Skepticism Among Physicians: Results of a National Survey.

Aaron S Kesselheim1, Joshua J Gagne1, Wesley Eddings1, Jessica M Franklin1, Kathryn M Ross2, Lisa A Fulchino1, Eric G Campbell3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27158897     DOI： 10.1001/jamainternmed.2016.1688

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  17 in total

1.  Comparison of Generic-to-Brand Switchback Rates Between Generic and Authorized Generic Drugs.

Authors:  Richard A Hansen; Jingjing Qian; Richard Berg; James Linneman; Enrique Seoane-Vazquez; Sarah K Dutcher; Saeid Raofi; C David Page; Peggy Peissig
Journal:  Pharmacotherapy       Date:  2017-03-20       Impact factor: 4.705

2.  Active Surveillance of Follow-on Biologics: A Prescription for Uptake.

Authors:  Ameet Sarpatwari; Joshua J Gagne; Nicole L Levidow; Aaron S Kesselheim
Journal:  Drug Saf       Date:  2017-02       Impact factor: 5.606

3.  Determinants of Generic Drug Substitution in the United States.

Authors:  Jodi B Segal; Oluwadamilola Onasanya; Matthew Daubresse; Chia-Ying Lee; Mischka Moechtar; Xia Pu; Sarah K Dutcher; Robert J Romanelli
Journal:  Ther Innov Regul Sci       Date:  2020-01-06       Impact factor: 1.778

4.  Bioequivalence and Therapeutic Equivalence of Generic and Brand Bupropion in Adults With Major Depression: A Randomized Clinical Trial.

Authors:  Evan D Kharasch; Alicia Neiner; Kristin Kraus; Jane Blood; Angela Stevens; Julia Schweiger; J Philip Miller; Eric J Lenze
Journal:  Clin Pharmacol Ther       Date:  2019-01-18       Impact factor: 6.875

5.  A Survey of Patients' Perceptions of Pill Appearance and Responses to Changes in Appearance for Four Chronic Disease Medications.

Authors:  Ameet Sarpatwari; Joshua J Gagne; Zhigang Lu; Eric G Campbell; Wendy J Carman; Cheryl L Enger; Sarah K Dutcher; Wenlei Jiang; Aaron S Kesselheim
Journal:  J Gen Intern Med       Date:  2019-01-10       Impact factor: 5.128

6.  Brand vs generic adverse event reporting patterns: An authorized generic-controlled evaluation of cardiovascular medications.

Authors:  Y Alatawi; Md M Rahman; N Cheng; J Qian; P L Peissig; R L Berg; C D Page; R A Hansen
Journal:  J Clin Pharm Ther       Date:  2017-11-01       Impact factor: 2.512

7.  Methodological Considerations for Comparison of Brand Versus Generic Versus Authorized Generic Adverse Event Reports in the US Food and Drug Administration Adverse Event Reporting System (FAERS).

Authors:  Md Motiur Rahman; Yasser Alatawi; Ning Cheng; Jingjing Qian; Peggy L Peissig; Richard L Berg; David C Page; Richard A Hansen
Journal:  Clin Drug Investig       Date:  2017-12       Impact factor: 2.859

8.  Historical Evolution and Provider Awareness of Inactive Ingredients in Oral Medications.

Authors:  Daniel Reker; Steven M Blum; Peter Wade; Christoph Steiger; Giovanni Traverso
Journal:  Pharm Res       Date:  2020-10-29       Impact factor: 4.200

9.  Development and testing of a module to promote generic oral contraceptive prescribing among nurse practitioners.

Authors:  Mark Chee; Gena Lenti; Jeanne Farnan; Michelle Cook; Arlene Weissman; September Wallingford; Christopher Moriates; Neel Shah; Shalini Lynch; Marilyn Stebbins; Samantha Ngooi; Allison Norenberg; Steven Millard; Anita Samarth; James X Zhang; David O Meltzer; Chris Tracy; Vineet M Arora
Journal:  J Am Assoc Nurse Pract       Date:  2020-01       Impact factor: 1.495

10.  Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending.

Authors:  Olivier J Wouters; Panos G Kanavos; Martin McKEE
Journal:  Milbank Q       Date:  2017-09       Impact factor: 4.911
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.